Donald Trump has announced a 100% tariff on patented pharma imports unless companies build US plants.
US President Donald Trump announced a massive new trade policy on Thursday, declaring that the United States will impose tariffs of up to 100 per cent on imported branded and patented pharmaceutical products starting October 1.
The move is explicitly designed to force drug manufacturing back onto American soil and could have significant repercussions for major foreign exporters, including Indian drugmakers.“Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America...” - President Donald J. Trump pic.twitter.com/z5EXQhw1xK— The White House September 25, 2025US President Donald Trump rolled out a huge new trade policy on Thursday, saying that the United States will place tariffs of 100 per cent or more on imported branded and patented medicine products from October 1. The action is specifically aimed at compelling drug manufacturing back to American shores and has serious implications for big foreign exporters, including Indian pharma companies.Zero Tariff For Made in AmericaThe tariff declaration, issued by Trump on his social media website Truth Social, unmistakingly connects exemption from the tax to local manufacturing.Beginning October 1st, 2025, we will be charging a 100% Tariff on any Branded or Patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America, the former President wrote.He further clarified the stringent conditions of exemption: IS BUILDING will mean, breaking ground and/or under construction. There will thus be no Tariff on these Pharmaceutical Products if construction has begun. Thank you for your consideration of the same!Possible Blow To Indian Drug ExportersThough Trumps remark has worldwide relevance, the across-the-board tariff on patented medicines will directly affect Indian drug firms which sell branded, patented, or specialty drugs to the US market. India is one of the worlds largest suppliers of drugs, and a 100% tariff would seriously undermine the competitive edge of these high-value exports unless firms invest substantial amounts to set up US-based operations.Broader Tariff BlitzPharma tariff is a part of a broader protectionist trade strategy unveiled by Trump. The declaration came along with new tariffs in several other industries, highlighting a protectionist trend in these sectors:50 per cent duty on foreign kitchen cabinets and vanities for bathrooms.30 per cent duty on upholstered furniture.25 per cent duty on heavy trucks.The new policy gives the worlds drug manufacturers a firm timeline: move their production into the United States or pay a prohibitively high tax on their patented drugs.ALSO READ | How Trump’s TikTok Deal Order Paves Way For US Ownership? Explained
Pharma Imports Indian Drugmakers Branded Pharmaceutical Products
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Indian Shrimp Export: अमेरिका का धोखा, चीन का एहसान... भारत को कैसे बहुत बड़े नुकसान से बचा लिया?अमेरिकी टैरिफ के कारण भारतीय झींगा निर्यातकों को एक बड़ा झटका लगा है। इससे वे चीन की ओर रुख करने को मजबूर हो गए हैं। चीन अब भारतीय झींगे का सबसे बड़ा खरीदार बनकर उभरा है, क्योंकि अमेरिका में भारतीय झींगे पर 50 फीसदी का टैरिफ लग गया है। इसने भारत को बहुत बड़े नुकसान से बचा लिया...
Read more »
ऑस्ट्रेलिया को नारियल का दूध, ईसबगोल की भूसी और चावल बेचकर मालामाल बन रहे भारतीय किसान, 1 साल की कमाई कर देगी हैरानभारत का ऑस्ट्रेलिया को जैविक निर्यात Indian Organic Export To Australia बढ़ा है जो वित्त वर्ष 2024-25 में 8.
Read more »
China-Germany का भारत पर ऐलान, Shashi Tharoor का बयान सुन रोया देश !Shashi Tharoor slams Indian diaspora over silence on India-US Tariff setbacks: भारत और अमेरिका के Watch video on ZeeNews Hindi
Read more »
Shreyas Iyer Rules Himself Out Of Selection Explained: ২০২৫ চ্যাম্পিয়ন্স ট্রফি জিতিয়েছেন, নির্বাচকরা আর ফিরেও তাকান না! অবশেষে অবহেলায় অবসর শ্রেয়সের?Shreyas Iyer Rules Himself Out Of Selection Explained
Read more »
US Overhauls H-1B Visa Selection: Top-Paid, High-Skill Foreign Talent Gets FavourThe United States will prioritise high-paid, high-skill foreign workers in the 2027 H-1B lottery, while new $100,000 petition fees and a weighted selection system reshape opportunities for applicants.
Read more »
US Tariffs: अमेरिकी राष्ट्रपति ट्रंप का एक और टैरिफ का एलान , दवाओं पर लगाया 100 प्रतिशत आयात शुल्कUS Tariffs: President Trump announces another tariff, imposing 100 percent import duty on medicines अमेरिकी राष्ट्रपति ट्रंप का एक और टैरिफ का एलान , दवाओं पर लगाया 100 प्रतिशत आयात शुल्क
Read more »